Global Estrogen Therapeutics Market 2018-2022| Increasing Awareness About Treatment of Menopausal Symptoms to Boost Demand| Technavio

Technavio has published a new market research report on the global estrogen therapeutics market from 2018-2022. (Graphic: Business Wire)

LONDON--()--Technavio analysts forecast the global estrogen therapeutics market to grow at a CAGR of over 2% during the forecast period, according to their latest market research report.

The evolution of estrogen as a therapeutic target in neurodevelopmental disorders is one of the major trends being witnessed in the global estrogen therapeutics market 2018-2022. Estrogen plays a primary role in the development of reproductive functions and sexual maturation in females. However, conclusive evidence from recent clinical tests and studies have proved that estrogens play a vital role in several brain functions, which include cognitive ability, learning and memory capacity, and neurodevelopment and adult neurogenesis.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

According to Technavio analysts, one of the key factors contributing to the growth of the global estrogen therapeutics market is the increasing awareness about the treatment of menopausal symptoms:

Global estrogen therapeutics market: Increasing awareness about the treatment of menopausal symptoms

The awareness about the negative impact of menopausal symptoms on the quality of life varies widely between countries and societies. In developed countries such as the US, Canada, Japan, and European countries, the knowledge regarding occurrence and impact of menopausal symptoms and their treatment is widespread due to public literacy and health programs. Besides these developed countries, the growing awareness about estrogen therapeutics and HRT in the emerging economies such as India or China is expected to drive the market during the forecast period.

According to a senior analyst at Technavio for research on infectious and rare diseases, “Menopausal symptoms include hot flashes, osteoporosis, fatigue, night sweats, pain during sexual intercourse, and insomnia which are caused due to insufficient production of estrogen hormones in the body. Estrogen therapeutics is effective for the treatment of such disorders and other estrogen deficiency mucosal symptoms and osteoporosis.”

Global estrogen therapeutics market: Segmentation analysis

The global estrogen therapeutics market research report provides market segmentation by product (estrogen gels, oral medication, suppositories, and skin patches), by estrogen type (estradiol, estrone, estetrol, and estriol), and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

Of the four major products, the estrogen gels segment held the largest market share in 2017, contributing close to 36% of the market. This product segment will dominate the global market throughout the forecast period.

The Americas held the largest share of the market in 2017, accounting for more than 56% share. It was followed by EMEA and APAC respectively. Although APAC held the smallest share of the market, it is expected to witness the maximum incremental growth over the forecast period.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market sizing
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

Technavio analysts forecast the global estrogen therapeutics market to grow at a CAGR of over 2% during 2018-2022, according to their report.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200